Recombinant Albumin Facilitates Formulation Design of Stable Drug Products - Recombinant albumin can stabilize a drug product and assist in the administration and release of the active component. - Bi

ADVERTISEMENT

Recombinant Albumin Facilitates Formulation Design of Stable Drug Products
Recombinant albumin can stabilize a drug product and assist in the administration and release of the active component.


BioPharm International
Volume 25, Issue 3, pp. 40-44

A MULTIFUNCTIONAL EXCIPIENT

Successful formulation of therapeutic proteins and peptides that ensures adequate stability, manufacturability, and usability is essential for the biopharmaceutical manufacturer. Excipients are commonly used within the industry to reduce protein degradation, which can occur through physical or chemical pathways.

In this study, a recombinant albumin was seen to function as an effective multifunctional excipient to protect proteins against aggregation, especially amyloid-like fibril products, act as an antioxidant in preventing protein oxidation, and as a blocking agent to prevent nonspecific adsorption to surfaces. rAlbumin has the potential to reduce the total number of excipients required, especially for difficult to formulate molecules, simplifying the formulation strategy and accelerating development time in achieving the desired properties for the finished drug product.

Mark Perkins is a customer solution specialist, Novozymes Biopharma,
.

REFERENCES

1. Crowley, P.J. and L.G. Martini, Chemistry Today 28 (5), 7–13 (2010).

2. F.G. Vogt and A.S. Kord, J. Pharm. Sci. 100 (3). 797–892 (2011).

3. S.S. Bharate, S.B. Bharate, and A.N. Bajaj, J. Excipients and Food Chemicals, 1 (3), 3–26 (2010).

4. ICH, Q1A(R2) Stability Testing of New Drug Substances and Products (2003).

5. J.R. Fransson, J. Pharm. Sci. 86 (9), 1046–1050 (1997).

6. M.E. Cromwell, M. E. Hilario, and F. Jacobson, The AAPS Journal 8 (3), 572–579 (2006).

7. W. Wang et al., J. Pharm. Sci. 96 (1), 1–6 (2007).

8. L.A. Kueltzo et al., J. Pharm. Sci. 97 (5), 1801–1812 (2008).

9. L. Perrone et al., ChemBioChem 11 (1), 110–118 (2010).

10. Y. Jeyachandran et al., Langmuir 25 (19), 11614–11620 (2009).


blog comments powered by Disqus

ADVERTISEMENT

EMD Millipore Collaborates with PharmaCell on Large-Scale, Cell-Culture Systems
May 23, 2013
SCHOTT Introduces Cartridge Design for High-Speed Filling
May 23, 2013
Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here